Source: Annual Congress 2003 - Lung cancer biology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. S. Savchenko, A. V. Bazhin, O. N. Shifrina, S. Y. Chikina, S. A. Demoura, E. A. Kogan, A. G. Chuchalin, P. P. Philippov (Moscow, Russia). Recoverin as a paraneoplastic antigen in lung cancer. Eur Respir J 2003; 22: Suppl. 45, 1335

Member's Comments

No comment yet.

Related content which might interest you: Antirecoverin autoantibodies in sera of patients with non-small cell lung cancer in the absence of cancer-associated retinopathy Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002 Symptoms and signs of lung cancer Source: Eur Respir Mon; 2009: 44: 71–87 Year: 2009 Symptoms, signs and staging of lung cancer Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=86 Year: 2001 Lung cancer and paraneoplastic syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 93s Year: 2006 Lung cancer and paraneoplastic acrosyndrome Source: Eur Respir J 2006; 28: Suppl. 50, 127s Year: 2006 Serum neuron-specific enolase - a marker for disease extent and response to therapy of small-cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 76s Year: 2004 A case of paraneoplastic limbic encephalitis associated with small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 91s Year: 2006 Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53 Source: Eur Respir J 2003; 21: 753-758 Year: 2003 Cytokeratins in lung cancer Source: Annual Congress 2003 - Lung cancer surgery: prognostic factors Year: 2003 Serum carcinoembryonic antigen (CEA) level as a predictive marker for distant metastasis in non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 85s Year: 2006 HER-2/neu oncoprotein expression in nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002 Procalitonin: A prognosis factor in lung cancer and a marker for small-cell lung cancer Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 Paraneoplastic syndromes in lung cancer patients Source: Eur Respir J 2001; 18: Suppl. 33, 66s Year: 2001 The prognostic significance of circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide and neuron- specific enolase in patients with advanced non-small-cell lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Lung cancer: immunopathology Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48 Year: 2001 Clinical and prognostic significance of autoantibodies against recoverin in non small cell lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 394s Year: 2003 Ras peptide-specific vaccination in patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2006 - Lung cancer treatment Year: 2006 Carcinoembryonic antigen mRNA analysis detects micrometastatic cells in blood from lung cancer patients Source: Eur Respir J 2003; 22: 418-421 Year: 2003 Increased risk of sarcoidosis among breast cancer patients; Breast cancer – sarcoidosis syndrome Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017 Clinical correlates and prognostic significance of neuron specific enolase (NSE) in non-small cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 73s Year: 2002